Volume 15 - Issue 11 - November 2018

Feature

Case Report

Causes and Management of Failing Unibody EVAR Grafts

11/21/2018

Patients treated with the lower-profile AFX Strata endograft have an increased risk of type III endoleak which may be treated with relining, according to a case report.

Patients treated with the...

11/21/2018

Vascular Disease Management

Endovascular Therapies

CFA, Profunda, and SFA Disease: Is There a Role for Endovascular Reconstruction When a Patient is Not a Surgical Candidate?

11/19/2018

Timothy E. Yates , MD, RPVI;

Omosalewa Adenikinju , MD;

Brandon P. Olivieri , MD, RPVI;

Sofia D.C. Vianna , MD;

Robert E. Beasley , MD, FSCAI, FSIR;

Available data suggest that common femoral artery atherosclerosis with or without patch angioplasty has a high 5-year patency rate and a relatively low rate of postoperative complications.

Available data suggest that...

11/19/2018

Vascular Disease Management

Column

Editor's Corner

The Role for Endovascular Reconstruction in CFA Disease

11/19/2018

Craig M. Walker , MD, FACC, FACP, FSCAI, FCCP;

Craig Walker, MD, opens the November issue of VDM by discussing the treatment of common femoral artery (CFA) disease in patients who are not surgical candidates for CFA endarterectomy.

Craig Walker, MD, opens the...

11/19/2018

Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

Double Win With Bridging Stents: FEVAR Certifications for BeGraft and BeFlared

11/20/2024

Hechingen, November 20th, 2024. With two certificates granted by TÜV, Bentley achieved another break-through in extending indications for its stents in complex aortic interventions. Thanks to one certificate, the Bentley BeGraft stent now is...

Hechingen, November 20th, 2024....

11/20/2024

Vascular Disease Management

First Aid guidelines

AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies

11/14/2024

These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.

These are the first major...

11/14/2024

Cath Lab Digest

Late-Breaking Trials

Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24

11/06/2024

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...

The VIVA Foundation, a...

11/06/2024

Vascular Disease Management

Late-Breaking Trials

Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24

11/05/2024

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...

The VIVA Foundation, a...

11/05/2024

Vascular Disease Management

Late-Breaking Trials

Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24

11/04/2024

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...

The VIVA Foundation, a...

11/04/2024

Vascular Disease Management

Late-Breaking Trials

First Round of Late-Breaking Clinical Trial Results Announced at VIVA24

11/04/2024

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...

The VIVA Foundation, a...

11/04/2024

Vascular Disease Management

Image-Guided Therapy

Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease

11/04/2024

With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...

With a unique world-first...

11/04/2024

Vascular Disease Management

Pulmonary Embolism

Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism

11/04/2024

QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...

QUADRA-PE study will evaluate...

11/04/2024

Vascular Disease Management

Peripheral Arterial Disease

FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease

11/04/2024

MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...

MOUNTAIN VIEW, Calif. – November...

11/04/2024

Vascular Disease Management

Patient Awareness

Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases

10/31/2024

New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...

New survey reveals nearly one in...

10/31/2024

Vascular Disease Management

Editorial Correspondence

Volume 15 - Issue 11 - November 2018

Feature

Column

Stay in the Know

News

November 2018 Volume 15 Issue 11

Specialties

Events

Year Round Education

HMP Global Products